Join the Respiratory Syncytial Virus group to help and get support from people like you.
Respiratory Syncytial Virus News
Related terms: Bronchiolitis, RSV
RSV Vaccination Effective Against Hospitalization in Patients 60 Years and Older
THURSDAY, Sept. 5, 2024 – For older adults, respiratory syncytial virus (RSV) vaccination is effective against RSV hospitalization, according to a study published online Sept. 4 in the Journal of...
RSV Infection With Inflammatory Bowel Disease Ups Risk for Hospitalization
WEDNESDAY, Aug. 28, 2024 – Adult patients with inflammatory bowel disease (IBD) and respiratory syncytial virus (RSV) infection have an increased risk for hospitalization, according to a study...
Wearing Face Mask Reduces Risk for Symptoms of Respiratory Infection
WEDNESDAY, July 31, 2024 – Wearing a surgical mask in public spaces is associated with a reduced risk for self-reported symptoms consistent with a respiratory infection, according to a study...
Nirsevimab Effective Against RSV-Linked Bronchiolitis Hospitalization
WEDNESDAY, July 10, 2024 – Nirsevimab therapy is effective for reducing the risk for hospitalization for respiratory syncytial virus (RSV)-associated bronchiolitis among infants, according to a...
Study Shows RSV Vaccine Abrysvo, Safe in Late Pregnancy
TUESDAY, July 9, 2024 – Expectant mothers who get vaccinated to protect their newborns against respiratory syncytial virus (RSV) are not putting themselves or their babies at risk, new research...
CDC Strengthens RSV Vaccine Advice for Those Over 75
THURSDAY, June 27, 2024 – In new vaccination guidance issued Wednesday, U.S. health officials now recommend that all Americans aged 75 and older get an RSV vaccine before fall arrives. However,...
Marked Increase in Pediatric RSV Hospitalizations Seen Postpandemic
TUESDAY, June 18, 2024 – Hospital volumes for pediatric respiratory syncytial virus (RSV) rose significantly following the pandemic, along with the need for advanced respiratory support in older...
FDA Gives Nod to RSV Vaccine, Arexvy, for People in Their 50s
MONDAY, June 10, 2024 – The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at...
FDA Approves mRESVIA (respiratory syncytial virus vaccine) for Prevention of Lower Respiratory Tract Disease Caused by RSV
CAMBRIDGE, MA / ACCESSWIRE / May 31, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), an mRNA respiratory...
Personalized Tool Can Predict Infants at Increased Risk for RSV
THURSDAY, May 9, 2024 – A personalized tool can predict infants at increased risk for severe respiratory syncytial virus (RSV) lower respiratory tract infection (LRTI) who would benefit most from...
Most Moms-to-Be Interested in RSV Vaccination During Pregnancy
THURSDAY, April 25, 2024 – More than half of women who are pregnant or planning to become pregnant are very likely to get vaccinated against respiratory syncytial virus (RSV) during pregnancy,...
RSV Burden in Children Under 5 Increased in 2021 and 2022 Versus 2015-2019
FRIDAY, April 19, 2024 – For children younger than 5 years, the incidence of respiratory syncytial virus (RSV) hospitalization increased in 2021 and 2022 compared with 2015 to 2019, according to a...
Acute Cardiac Event Reported in 22.4 Percent of Seniors Hospitalized With RSV
MONDAY, April 15, 2024 – More than 22 percent of older hospitalized adults with respiratory syncytial virus (RSV) infection experience an acute cardiac event, according to a study published online...
Disease Severity Similar for RSV as Unvaccinated COVID-19, Influenza
FRIDAY, April 5, 2024 – Disease severity is similar for patients hospitalized with respiratory syncytial disease (RSV) and unvaccinated adults with COVID-19 or influenza, according to a study...
Many U.S. Seniors Do Not Intend to Vaccinate Against RSV
WEDNESDAY, March 13, 2024 – Many U.S. seniors do not intend to vaccinate against respiratory syncytial virus (RSV) in the 2023 to 2024 season, according to a study published online Jan. 19 in Health...